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Following brain injury, microglia assume a reactive-like state and secrete pro-inflammatory
molecules that can potentiate damage. A therapeutic strategy that may limit microgliosis
is of potential interest. In this context, selective estrogen receptor modulators, such
as raloxifene and tamoxifen, are known to reduce microglia activation induced by
neuroinflammatory stimuli in young animals. In the present study, we have assessed
whether raloxifene and tamoxifen are able to affect microglia activation after brain injury in
young and aged animals in time points relevant to clinics, which is hours after brain trauma.
Volume fraction of MHC-II+ microglia was estimated according to the point-counting
method of Weibel within a distance of 350 µm from the lateral border of the wound, and
cellular morphology was measured by fractal analysis. Two groups of animals were studied:
(1) young rats, ovariectomized at 2 months of age; and (2) aged rats, ovariectomized at
18 months of age. Fifteen days after ovariectomy animals received a stab wound brain
injury and the treatment with estrogenic compounds. Our findings indicate that raloxifene
and tamoxifen reduced microglia activation in both young and aged animals. Although
the volume fraction of reactive microglia was found lower in aged animals, this was
accompanied by important changes in cell morphology, where aged microglia assume a
bushier and hyperplasic aspect when compared to young microglia. These data suggest
that early regulation of microglia activation provides a mechanism by which selective
estrogen receptors modulators (SERMs) may exert a neuroprotective effect in the setting
of a brain trauma.
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INTRODUCTION
Microglia are considered as the macrophages of the brain. Trauma
to the brain causes increased production of reactive oxygen
species and oxidative stress, neuronal damage (Barreto et al.,
2011) and elicits activation of astrocytes and microglia. Microglia
respond to brain insults by activation, assuming a reactive
state, which involves increased production of pro-inflammatory
molecules, including chemokines, cytokines, adhesion molecules,
metalloproteinases, hyperplasia of cell body and hypertrophy of
cellular processes (Aloisi, 2001; Loane and Byrnes, 2010; Xiong
et al., 2011; Hernandez-Ontiveros et al., 2013). Increased on site
inflammation may prevent tissue recover and repair (Adelson
et al., 2012), and a therapeutic strategy that may limit the release
of molecules that potentiate damage is of potential interest.
Estrogens may exert neuroprotection after brain injury by
regulating reactive astrocytes and microglia (Garcia-Estrada et al.,
1993; García-Estrada et al., 1999; Barreto et al., 2007, 2009).
Despite these protective effects of estradiol on brain, this hormone
may produce some side effects in peripheral tissues, especially
in women submitted to post-menopausal hormonal therapy. The
transcriptional activity of estrogen receptors (ER) is regulated by
their association with transcriptional cofactors that have a tissue
or cell specific expression (Klinge, 2000; Belandia and Parker,
2003). Therefore, in this context, several estrogen receptor lig-
ands, known as selective estrogen receptors modulators (SERMs),
are able to exert tissue specific actions, acting as ER agonists in
some tissues and as ER antagonists in others. Although the effect
of estradiol on brain after damage is well explored, the role that
SERMs may have is not clear.
Previous studies showed that raloxifene and tamoxifen, two
known SERMs used in clinics, reduce microglial activation
induced by lipopolysaccharide (Suuronen et al., 2005; Tapia-
Gonzalez et al., 2008), irradiaton-induced brain injury (Liu et al.,
2010), and spinal cord injury (Ismailog˘lu et al., 2010, 2013).
Although these studies demonstrate a potential effect of SERMs
on the inflammation resolution following different brain insults,
all of them focused on young subjects. Although one study has
demonstrated that raloxifene reduces the number of microglia
cells in the hippocampus of female mice during aging (Lei et al.,
2003), it is unknown if SERMs maintain their potency to decrease
reactive microgliosis after brain injury in aged animals. Therefore
in this study we have compared the effects of raloxifene and
tamoxifen on reactive microgliosis after brain injury in young and
aged female rats.
Frontiers in Aging Neuroscience www.frontiersin.org June 2014 | Volume 6 | Article 132 | 1
Barreto et al. SERMs reduce microglia after TBI
MATERIALS AND METHODS
ANIMALS AND EXPERIMENTAL TREATMENTS
Wistar albino female rats from the Complutense University ani-
mal colony (Madrid, Spain) were kept on a 12:12 h light/dark
schedule and received food and water ad-libitum. Animals were
handled in accordance with the guidelines published in the NIH
Guide for the Care and Use of Laboratory Animals, the principles
presented in the Guidelines for the Use of Animals in Neuro-
science Research by the Society for Neuroscience and following
the Spanish Royal Decree 53/2013 about protection of experimen-
tal animals, in close agreement with the European Communities
Council Directives 86/609/EEC and 2010/63/UE. Experimental
procedures were approved by our institutional animal use and
care committee. Special care was taken to minimize suffering and
to reduce the number of animals used to the minimum required
for statistical accuracy.
EXPERIMENTAL DESIGN
In this study we have assessed the effect of estradiol, raloxifene and
tamoxifen on reactive microglia in ovariectomized rats, a model
that imitates menopause. To determine whether the effects of
estrogenic compounds are altered by aging, we studied two groups
of animals: (1) young rats ovariectomized at 2 months of age; and
(2) aged rats castrated at 18 months of age. All animals received
brain injury 15 days after ovariectomy.
BRAIN INJURY
Animals were bilaterally ovariectomized under halothane anes-
thesia (Fluothane, AstraZeneca Farmacéutica, Madrid, Spain).
For brain surgery, animals were anesthetized with halothane
and placed in a stereotaxic apparatus (David Kopf Instruments,
Tujunga, CA, USA). An incision of the scalp was made and the
cranium exposed. Then, a unilateral opening of the skull was
made with a dental drill. A solid stainless steel cannula, with a
0.45 mm outer diameter, was used to make a longitudinal stab
wound in the left hemisphere. The cannula was positioned at
2 mm lateral to the midline in young rats, at 2.4 mm lateral to
the midline in aged rats and at 2 mm posterior to bregma in both
age groups and introduced into the brain until the tip reached a
depth of 5.5 mm. Then, the cannula was displaced caudally 3 mm
(bregma: −5 mm) and finally removed from the brain. Bleeding
was inhibited by compression with a gel-foam sponge. The scalp
wound was sutured with surgical silk.
TREATMENTS WITH ESTROGENIC COMPOUNDS
Animals received one subcutaneous injection of 17β-estradiol
(E2758, Sigma-Aldrich, St. Louis, Mo; 100 µg/Kg), raloxifene
(R1402, Sigma-Aldrich, 1 mg/Kg), and tamoxifen (T5648, Sigma-
Aldrich, 1 mg/Kg) after injury, a second injection 24 h later and
a third injection 48 h later. Thus, the estrogenic compounds were
administered during the period of glial activation, and doses of
estradiol and estrogenic compounds were selected on the basis
of previous studies. This dose of estradiol is known to stimulate
neuroprotective signaling cascades and to exert neuroprotection
in the hippocampus (Barreto et al., 2009). These effects may be at
least in part due to the high levels of the hormone achieved shortly
following the injections. The doses of raloxifene and tamoxifen
were previously shown to be neuroprotective in a model of brain
trauma in vivo and to reduce microglial activation in a model of
brain inflammation (Tapia-Gonzalez et al., 2008; Barreto et al.,
2009).
TISSUE FIXATION AND IMMUNOHISTOCHEMISTRY
One week after brain injury, animals were deeply anesthetized
with pentobarbital (100 mg/kg, Normon Veterinary Division,
Madrid, Spain) and perfused through the left cardiac ventricle,
first with 50 ml saline solution (0.9% NaCl) and then with 250 ml
fixative solution (4% paraformaldehyde in 0.1 M phosphate
buffer, pH 7.4). Brains were removed and immersed overnight at
4◦C in the same fixative solution and then rinsed with phosphate
buffer. Coronal sections of the brain, 50 µm thick, were obtained
using a Vibratome (VT 1000 S, Leica Microsystems, Wetzlar,
Germany).
Immunohistochemistry was carried out on free-floating sec-
tions under moderate shaking. All washes and incubations were
done in 0.1 M phosphate buffer pH 7.4, containing 0.3%
bovine serum albumin and 0.3% triton X-100. The endoge-
nous peroxidase activity was quenched for 10 min at room
temperature in a solution of 3% hydrogen peroxide in 30%
methanol. After several washes in buffer, sections were incu-
bated overnight at 4◦C with a mouse monoclonal antibody
for the Mayor Histocompatibility Complex type II (MHC-
II; MRC-OX6, MCA46G, Serotec, Bicester, UK; diluted 1:300),
a marker of reactive microglia. Sections were then rinsed
in buffer and incubated for 2 h at room temperature with
biotinylated goat anti-mouse immunoglobulin G (diluted 1:300;
Pierce, Rockford, IL, USA). After several washes in buffer, sec-
tions were incubated for 90 min at room temperature with
avidin-biotin-peroxidase complex (diluted 1:250; ImmunoPure
ABC peroxidase staining kit, Pierce). The reaction product
was revealed by incubating the sections with 2 µg/ml 3,3′-
diaminobenzidine (Sigma-Aldrich) and 0.01% hydrogen peroxide
in 0.1M phosphate buffer. Some sections were counterstained
with toluidine blue. Then, sections were dehydrated, mounted
on gelatinized slides, coverslipped and examined with a Leica
DMRB-E microscope.
MORPHOMETRIC ANALYSIS
Only brains that showed a complete lesion from the dorsal to
the ventral limit of the dorsal hippocampus were selected for
morphometry. The high density of MHC-II immunoreactive cell
bodies and processes in the proximity of the wound impeded the
accurate identification of individual cells. Therefore, the volume
fraction of MHC-II immunoreactive microglia was estimated
according to the point-counting method of Weibel (1979). The
outline of the hippocampus lateral to the border of the wound
and the areas filled with immunoreactive material were drawn on
a paper using a Leitz microscope equipped with a camera lucida.
A transparent point grid was superimposed on the drawings. The
total number of points falling on the hippocampus (reference
volume) and the number of points falling on immunoreactive
material were counted within a distance of 350 µm from the
lateral border of the wound. The area associated to each point
was 614 µm2. The volume fraction of immunoreactive material
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was calculated for each animal as the ratio of the sum of the
number of points falling on immunoreactive material vs. the sum
of the number of points falling in the reference volume. At least
three sections were evaluated for each animal. All counts were
performed on coded sections and drawings.
MORPHOLOGICAL ASSESSMENT
Preselection of reactive microglia
The MHC-II+ microglia examined in this section were located
in the stratum radiatum at a distance of 100–200 µm from the
wound. Only cells with visible nuclei and complete processes not
damaged by tissue sectioning were selected for analysis. Cells were
selected randomly using a scale generated automatically (available
on the Internet).1
Image acquisition
Black and white images of MHC-II+ microglia were obtained
using a digital camera attached to a Zeiss axiovert inverted fluo-
rescent microscope (Zeiss, Germany). The images were processed
using ImageJ software (developed at the USA National Institutes
of Health and available on the Internet).2 Under a 40X objective,
cells were picked randomly in each selected area, and the binary
overlay of a cell was created using thresholding procedure. In this
method, all pixels with their gray level values higher than the
threshold value were treated as belonging to the cell image. Other
pixels were treated as background. For each cell the appropriate
threshold value was defined manually at the level at which the
binary overlay completely covered the whole cell body and pro-
cesses. Finally, the binary silhouette of the whole cell was reduced
to its one-pixel outline for estimation of the fractal dimensions
with the FracLac 2.5 ImageJ plug-in (A. Karperien, Charles Stuart
University).
QUANTITATIVE FRACTAL ANALYSIS
Fractal analysis was carried out on binary images using dilation
method. The method, originally devised by Flook (1978), is based
on the Minkowski-Bouligand dimension (Mandelbrot). The sim-
ple method can be easily assessed by typical image processing
software, so is very often used to determine the fractal dimension
of cell images. With this method, each pixel in the cell outline
was replaced with a disk of a diameter varying from 3–61 pixels.
Then the area of the widened outline divided by the diameter of
structuring element was plotted against this diameter in a log-log
scale. The slope of the regression line (S) is related to the fractal
dimension (D) by D = 1− S. In addition, the following variables
were measured in this study: the area of the cell silhouette (the
cell area), and the arbor area—the area of the convex polygon
obtained by connecting the tips of the longest astrocytic processes
(also known as the convex hull area). We measured the solidity
factor, obtained by the division of the cell silhouette by the arbor
area, and lacunarity values.
STATISTICAL ANALYSIS
The n used for statistical analysis was the number of animals
(n = 4–6). Data were analyzed by one-way analysis of variance
1http://www.random.org/integers
2http://rsb.info.nih.gov/ij/
(ANOVA) followed by the Tukey post hoc test for paired compar-
isons, with p < 0.05 considered to be significant. For comparison
of two variables (age and treatment), data were analyzed by two-
way ANOVA followed by Bonferroni post-tests to determine the
interaction of aging and treatment, or each factor alone.
RESULTS
SERMs DECREASE REACTIVE MICROGLIA IN YOUNG ANIMALS
The qualitative inspection of the sections immunostained for
MHC-II to detect reactive microglia revealed a prominent
microgliosis along the borders of the wound in both young and
aged animals treated with vehicle. However, animals treated with
estradiol, raloxifene, tamoxifen showed a lower cellular density
compared to vehicle animals (Figures 1 and 2).
The morphometric analysis with the Weibel method con-
firmed the qualitative observations. The volume fraction of
MHC-II immunoreactive microglia showed a significant decrease
in the young animals that received estradiol (P = 0.009), ralox-
ifene (P = 0.002) and tamoxifen (P = 0.049) in early treatment
(Figure 3).
EFFECTS OF AGING AND SERMs ON REACTIVE MICROGLIA AFTER
INJURY
To assess the effect of estrogenic compounds on reactive microglia
in aged animals following traumatic brain injury, we measured
microglia volume fraction and changes in cell morphology by
fractal analysis. Our previous observations showed that the age
affected the cellular density in animals injected with vehicle
(Figure 2), and that the SERMs reduced the fraction of reac-
tive microglia reactive bordering the wound. To support these
statements, we assessed the volume fraction of reactive microglia
in aged animals after the treatment with estrogenic compounds.
Reactive microglia were significantly less numerous in animals
FIGURE 1 | MHC-II immunoreactive microglia in the CA1 stratum
radiatum at a distance of approximately 100–200 µm from the lateral
border of the wound in young animals. The panels illustrate
representative examples from ovariectomized young rats after
administration of (V) vehicle, (E) estradiol, (R) raloxifene or (T) tamoxifen. All
figures are at the same magnification. Scale bar, 50 um.
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FIGURE 2 | MHC-II immunoreactive microglia in the CA1 stratum
radiatum at a distance of approximately 100–200 µm from the lateral
border of the wound in aged animals. The panels illustrate representative
examples from ovariectomized aged rats after administration of (V) vehicle,
(E) estradiol, (R) raloxifene or (T) tamoxifen. All figures are at the same
magnification. Scale bar, 50 um.
FIGURE 3 | Volume fraction of MHC-II immunoreactive microglia within
a distance of 350 µm from the lateral border of the wound in young
and aged animals injected with vehicle (Veh) n = 6 (young) and 5
(aged), estradiol (Est) n = 4 (young and aged), raloxifene (Ralox) n = 6
(young) and 4 (aged), or tamoxifen (Tamox) n = 5 (young) and 4 (aged).
Data are represented as means +/− SEM. * Significant difference (P <
0.05) vs. vehicle values. * P < 0.05 vs. vehicle (young); # P < 0.05 vs.
vehicle (aged); $ P < 0.05 young vs. aged treated with same SERM.
treated with estradiol (P = 0.03), raloxifene (P = 0.02) or tamox-
ifen (P = 0.006) (Figure 3).
CORRELATION OF MICROGLIA REACTIVITY AND MORPHOLOGY WITH
AGING AND TREATMENT
Two-way ANOVA showed no interaction between age and treat-
ment in reactive microglia (P = 0.66). On the other hand, each
factor alone, age (F = 7.136; P = 0.0121) or treatment (F =
12.65; P < 0.0001) affects microglia immunoreactive for MHC-
II (Figure 3).
FIGURE 4 | (A) The upper panel indicates age differences on microglia
morphology with aging in animals treated with vehicle. Fractal analysis
shows that microglia reactivity is characterized by changes in both cell body
and processes. (B) Cell shape is hypertrophied and bushier in control cells
(vehicle, V) compared to those cells from animals treated with estradiol
(Est), raloxifene (Ralox) or tamoxifen (Tamox). * P < 0.05 vs. vehicle
(young); # P < 0.05 vs. vehicle (aged); $ P < 0.05 young vs. aged treated
with same SERM.
To quantitatively assess microglia morphology in response to
brain injury with aging, we performed fractal analysis (Barreto
et al., 2012) of selected individual cells from the same area used
for counting. Changes in the complexity of microglia expressing
MHC-II were quantified by calculating cell area, arbor area, frac-
tal dimension, and lacunarity values. In the injured brains, MHC-
II+ microglia assumed a wide spectrum of forms, from small
cells with short to large, well-developed cells after penetrating
injury in aged animals. Our results show that cell complexity
increases with aging (Figure 4A). The cell (P < 0.0001) and arbor
(P < 0.0001) areas were lower in young animals treated with
SERMs, in comparison to those in vehicle (Figure 4B), reflecting
a decreasing microglia cell body and processes when SERMs treat-
ments are administered. With respect to the fractal dimension
(Figure 4B), the mean values characterizing the SERMs post-
injury groups were lower (P < 0.0001) than those observed in
vehicle. We also analyzed lacunarity values, which are sought to
be a measure of non-uniformity (heterogeneity) of structure or
the degree of structural variance within an object, in this case
how complex microglia are. Significant high lacunarity values
are found in estradiol (P = 0.0002), raloxifene (P = 0.0006) or
tamoxifen (P < 0.0001) treated young animals, in comparison to
low values in vehicle (Figure 4B). For cell morphology analysis
in aged animals, we observed significant differences in cell and
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arbor areas (P < 0.0001 for both parameters), fractal dimension
(P < 0.0001) and lacunarity (P < 0.0001) in animals treated with
SERMs in comparison to vehicle-treated subjects (Figure 4B),
suggesting an increased complexity of microglia after injury,
and that SERMs were able to reduce the reactive state of these
cells.
An effect of treatment was observed in all analyzed parameters:
Cell area (F = 52.63; P < 0.0001), arbor area (F = 67.43; P <
0.0001), Fractal dimension (F = 102.4; P< 0.0001) and lacunarity
(F = 85.52; P < 0.0001). On the contrary, age alone only affects
cell area (F = 36.43; P < 0.0001), arbor area (F = 58; P < 0.0001)
and fractal dimension (F = 988.3; P < 0.0001). Two-way ANOVA
showed no significant interaction between aging and treatment
only in lacunarity (P = 0.61) (Figure 4B).
DISCUSSION
Microglia become more activated and reactive with aging and
assume different morphological states (Peters et al., 1991; Ogura
et al., 1994; Sheffield and Berman, 1998; Ye and Johnson,
1999; Kumar et al., 2013) indicating that this altered state may
potentiate damage and increase inflammation following brain
injury. In the present study we assessed the volume fraction of
microglia immunoreactive for MHC-II and analyzed their mor-
phology in young and aged animals subjected to penetrating brain
injury. Our findings indicate that SERMs were able to decrease
microgliosis, which can be interpreted as the fraction of reactive
microglia and the morphological aspect these cells assume bor-
dering the wound. Previous studies have shown that estrogen and
the SERM, raloxifene, reduce microglia in aged female mice (Lei
et al., 2003), demonstrating a potential neuroprotective action by
modulating reactive glia.
The aim of our study was to assess whether SERMs were
able to reduce microglia activation in aged females under con-
ditions that imitate menopause. After reproductive aging, rats
may enter in constant estrus or constant diestrus. Indeed, Wistar
female rats in our colony still maintain relatively high estrogen
levels in plasma at 18 months (68 ± 9 pg/ml−1). Thus, aged
female rats are not a good model for menopause. To imitate
menopause is necessary to use ovariectomized rats. We com-
pared aged ovariectomized animals with young ovariectomized
animals. Both groups of animals represent models of menopause,
but in our experimental design we include the variable age.
Interestingly, previous evidences have shown a correlation with
aging and/or menopause with increased traumatic brain injury
(Onyszchuk et al., 2008; Sandhir et al., 2008; Kumar et al., 2013;
Sun et al., 2013), supporting our experimental approach as a
reliable model to study the effects of aging and menopause in
injured animals.
Previous studies reported the kinetics of microglia activation
in aged brain (Kyrkanides et al., 2001; Sandhir et al., 2008), but
this is the first study to assess this activated state of microglia in
aged vs. young subjects, and propose the SERMs as a potential
therapy to control microgliosis, even in animals with advanced
aging. Concerning the treatment scheme: (i) we sought to assess
SERMs effectiveness in time points relevant to clinics, which is
hours after brain trauma; (ii) this period reflects the initial stage
of microglia activation, and we hypothesized that raloxifene and
tamoxifen regulate the activated state of microglia in the first
48 h following injury; and (iii) the doses of SERMs used in the
present have been previously shown to be effective to control
astrogliosis following penetrating brain injury (Barreto et al.,
2009).
Activation of microglia was reported to be neuroprotective
in ischemic models (Lalancette-Hébert et al., 2007), despite
its harmful effects to neurons when activation is excessive
(Heppner et al., 2005; Marchetti and Abbracchio, 2005). A
proper control of microglial reactivity by SERMs may rep-
resent a potential therapeutic strategy in brain injuries. The
SERMs may have actions on reactive microglia via estrogen
receptor (ER) signaling, as these cells express both ERβ (Taka-
hashi et al., 2004) and ERα (Sierra et al., 2008; Tapia-Gonzalez
et al., 2008). The expression of the latter may indicate that
part of the anti-inflammatory effects of SERMs on microglial
cells is sought to happen by activation of this classical estro-
gen receptor. Interestingly, some unpublished data from our lab
demonstrate that reactive microglia is reduced in young ani-
mals treated with 2,3-bis(4-hydroxyphenyl)-propionitrile (DPN)
(estrogen receptor beta agonist; 93.95 ± 2.41), 4,4′,4′′-(4-propyl-
[1H]-pyrazole-1,3,5-triyl)trisphenol (PPT) (68.99 ± 6.42) and
combined DPN+PPT (52.99 ± 2.23) in comparison to controls
(184.28 ± 15.59), suggesting that both receptors may be mediat-
ing these protective effects in our model. Besides SERMs effects
on microglia activation (Suuronen et al., 2005; Tapia-Gonzalez
et al., 2008; Liu et al., 2010; Arevalo et al., 2012), previous studies
also showed that raloxifene and tamoxifen induced upregula-
tion of glutamate transporters (Karki et al., 2014), potentiation
of mitochondrial superoxide dismutase (Wakade et al., 2008),
improves functional outcome following spinal cord injury (Tian
et al., 2009), and reduces inflammation via estrogen receptor
beta (Baker et al., 2004). Since traumatic brain injury induces
a complex cascade of events, which involves increased produc-
tion of pro-inflammatory molecules, activating microglia, thus
augmenting tissue damage and neuronal death, SERMs may act
by decreasing the production of inflammatory cytokines secreted
by microglia and improve the outcome in both aged and young
subjects.
Interestingly, we observed that the volume fraction of MHC-
II microglia is lower in aged animals in comparison to young
subjects. These observations are supported by other reports,
where microglia is found reduced in aged rat brain following
excitotoxic damage (Campuzano et al., 2011), intracerebral hem-
orrhage (Wasserman and Schlichter, 2008) and with normal aging
(Cerbai et al., 2012). Although our results indicate that reactive
microglia is decreased in aged animals, and that SERMs lowered
this number, the reactive-like state of microglia, assessed by
fractal analysis, in aged subjects is higher than that from young
animals.
Microglia morphology at different states has been widely
assessed by fractal analysis (Soltys et al., 2001, 2005; Karperien
et al., 2013; Torres-Platas et al., 2014). An important goal in many
branches of science, especially in cellular biology and medicine is
the quantitative analysis of the structures and their morphology.
The morphology can be analyzed in many ways, such as filling
cells with Lucifer yellow dye (Wilhelmsson et al., 2006), or in
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particular by the fractal analysis (Schaffner and Ghesquiere, 2001;
Soltys et al., 2001, 2005; Barreto et al., 2012). In the present
study, the quantitative analysis showed that the volume fraction of
MHC-II-immunoreactive microglia decreased when animals are
treated with SERMs. To assess microglia morphology in response
to brain injury, we assigned a fractal dimension to randomly
picked individual microglia from the same area indicated above.
Other parameters, thus, can also be assessed, including cell and
arbor areas. We observed that cell and arbor area increased in
vehicle-treated young animals, indicating important changes in
the cell body and processes. Upon treatment with SERMs, cell
complexity is found reduced in young animals. Fractal dimen-
sions provided a measure of how completely an object fills a
specified region, in this case how microglia cellular body and
processes fill a specific area. Apart from the fractal dimension, an
important part of the fractal analysis is the lacunarity measure-
ment which, roughly describing, characterizes the distribution
of gaps in the fractal. We showed here that lacunarity values
increase in young animals treated with SERMs, indicating “low
complexity” of a given object. If we apply these concepts into
our study, microglia in animals treated with SERMs have lesser
branches and processes, and smaller cell bodies compared to
vehicle, which is characterized by larger and increased number of
processes and a hypertrophied cellular body.
Effects of aging on microglial morphology upon injury are
also noted. Aged reactive microglia assume a bushier and hyper-
plasic shape when compared to young microglia. Indeed, fractal
dimension, a measure of complexity, indicates that aged microglia
present significant higher values in comparison to young animals.
These observations demonstrate that, although the number of
reactive microglia is found reduced in aged animals, microglia
in these animals are more reactive, and that SERMs were able to
regulate this activated-like state.
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